Can gene therapy ever live down its setbacks and live up to its initial promise? A chastened but determined group of pioneers believes it can, and they are pointing to a new generation of products to back up that claim.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The Memory-Modifying Potential of Optogenetics and the Need for Neuroethics
NanoEthics Open Access 17 October 2020
-
Construction and Characterization of an in-vivo Linear Covalently Closed DNA Vector Production System
Microbial Cell Factories Open Access 06 December 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Branca, M. Gene therapy: cursed or inching towards credibility?. Nat Biotechnol 23, 519–521 (2005). https://doi.org/10.1038/nbt0505-519
Issue Date:
DOI: https://doi.org/10.1038/nbt0505-519
This article is cited by
-
The Memory-Modifying Potential of Optogenetics and the Need for Neuroethics
NanoEthics (2020)
-
Construction and Characterization of an in-vivo Linear Covalently Closed DNA Vector Production System
Microbial Cell Factories (2012)
-
Gene therapy finds its niche
Nature Biotechnology (2011)
-
Ark's gene therapy stumbles at the finish line
Nature Biotechnology (2010)
-
Ark floats gene therapy's boat, for now
Nature Biotechnology (2008)
